| CTRI Number |
CTRI/2025/04/085702 [Registered on: 25/04/2025] Trial Registered Prospectively |
| Last Modified On: |
24/04/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
Effect of sarpgandha churna yoga in anidra(insomnia) |
|
Scientific Title of Study
|
A Clinical study of Sarpagandha churna yoga in the management of Anidra with special reference to Insomnia |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| Nil |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Avinash kumar |
| Designation |
MD(Ayu)Scholar |
| Affiliation |
Institute of medical science Bhu |
| Address |
Department of Kayachikitsa Dhanwantri Bhawan Faculty of Ayurveda Institute of medical science Banaras Hindu University Varanasi UP
Varanasi UTTAR PRADESH 221005 India |
| Phone |
9125505179 |
| Fax |
|
| Email |
kumar.avinash110@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Prof K H H V S S Narasimha Murthy |
| Designation |
professor |
| Affiliation |
Institute of medical science Bhu |
| Address |
Department of Kayachikitsa Dhanwantri Bhawan Faculty of Ayurveda Institute of medical science Banaras Hindu University Varanasi UP
Varanasi UTTAR PRADESH 221005 India |
| Phone |
9415813570 |
| Fax |
|
| Email |
k_narasimhamurthy@yahoo.co.in |
|
Details of Contact Person Public Query
|
| Name |
Prof K H H V S S Narasimha Murthy |
| Designation |
professor |
| Affiliation |
Institute of medical science Bhu |
| Address |
Department of Kayachikitsa Dhanwantri Bhawan Faculty of Ayurveda Institute of medical science Banaras Hindu University Varanasi UP
Varanasi UTTAR PRADESH 221005 India |
| Phone |
9415813570 |
| Fax |
|
| Email |
k_narasimhamurthy@yahoo.co.in |
|
|
Source of Monetary or Material Support
|
| Department of Kayachikitsa faculty of Ayurveda IMS BHU Varanasi Uttar Pardesh 221005 India |
|
|
Primary Sponsor
|
| Name |
Department of Kayachikitsa |
| Address |
Dhanwantri Bhawan, Faculty of Ayurveda IMS BHU Varanasi Uttar pradesh 221005 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Avinash kumar |
Sir Sundar Lal Hospital BHU Varanasi |
Kayachikitsa OPD Room no.21-22 Indian medicine wing Banaras Hindu University Varanasi 221005 Varanasi UTTAR PRADESH |
9125505179
kumar.avinash110@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethical committee institute of medical science bhu |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:G470||Insomnia. Ayurveda Condition: NIDRANASAH/ASVAPNAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Sarpagandha churna yoga, Reference: Rasatanta sar va siddha prayoga samgraha part 2, Route: Oral, Dosage Form: Churna/ Powder, Dose: 1000(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: - | | 2 | Comparator Arm (Non Ayurveda) | | - | Tab. Placebo | it contains gelatin filled capsule |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
50.00 Year(s) |
| Gender |
Both |
| Details |
Patients presenting with complaints of Reduction of sleep time, Difficulty in initiation of sleep, Wakefulness during normal sleep, either any of these or all of these for the duration of 3 months or more. Criteria for diagnosis-Based on classical signs and symptoms of Anidra |
|
| ExclusionCriteria |
| Details |
Patient above 50 years.
Patients with severe psychic disease.
Patient with moderate and severe hypertension, Stroke, Hemorrhagic disorders, Epilepsy.
Patient with alcohol dependency or drug dependency will be excluded from study.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| assessment of improvement in sign and symptom of insomina disease and athens insomnia scale and pittsburgh sleep quality index |
45 days with 3 follow up 15,30,45 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| assessment of improvement in subjective & objective criteria of insomnia |
0, 15,30,45 days assessment with follow-ups in subjective & objective criteria |
|
|
Target Sample Size
|
Total Sample Size="70" Sample Size from India="70"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
05/05/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Insomnia is most prevalent sleep disorder in current Era. In this study the effect of sarpagandha churna yoga and placebo will be used in the management of insomnia. Patient will be selected on the basis of subjective and objective criteria .The assessment of result will be based on clinical and subjective assessment of patient during the trial period. |